Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG20034)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
hsa-miR-30e-5p
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
Responsed Disease | Endotheliitis | ICD-11: 1F00 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
AMPK signaling pathway | hsa04152 | |||
Cell Process | Cell ferroptosis | |||
In Vitro Model |
hEPCs (Endothelial progenitor cells) | |||
HUVECs (Human umbilical vein endothelial cells) | ||||
Response regulation | EPCs-Exos inhibited Erastin-induced HUVEC ferroptosis and endothelial injury. EPCs-Exos promoted the activation of the AMPK pathway by upregulating the expression of miR-30e-5p in HUVECs and inhibiting the expression of SP1 in HUVECs, thus inhibiting Erastin-induced cell ferroptosis. | |||
Endotheliitis [ICD-11: 1F00]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
Target Regulator | hsa-miR-30e-5p (miRNA) | miRNA | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
AMPK signaling pathway | hsa04152 | |||
Cell Process | Cell ferroptosis | |||
In Vitro Model |
hEPCs (Endothelial progenitor cells) | |||
HUVECs (Human umbilical vein endothelial cells) | ||||
Response regulation | EPCs-Exos inhibited Erastin-induced HUVEC ferroptosis and endothelial injury. EPCs-Exos promoted the activation of the AMPK pathway by upregulating the expression of miR-30e-5p in HUVECs and inhibiting the expression of SP1 in HUVECs, thus inhibiting Erastin-induced cell ferroptosis. | |||
References